Success Rate of Wire Control-Assisted ERCP Sphincterotomy Versus Non-assisted ERCP Cannulation of Common Bile Duct in a Secondary Care Unit During the First COVID-19 Peak: A Retrospective Observational Study of 281 Patients.

common bile duct (cbd) covid 19 endoscopy ercp non-assisted ercp sphincterotomy wire control-assisted ercp

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Sep 2021
Historique:
accepted: 09 09 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 16 9 2021
Statut: epublish

Résumé

Background The British Society of Gastroenterology (BSG) recommended that during the COVID-19 pandemic, endoscopy units perform endoscopic retrograde cholangiopancreatography (ERCP) for obstructive biliary pathologies in an emergency. We assessed the local performance of ERCP during the first wave of COVID-19 at our local endoscopy center, in particular the technique to common bile duct (CBD) cannulation. Methodology All ERCP procedures performed from January to June 2020 were retrospectively assessed and compared with procedures performed between January and June 2019 at the Royal Lancaster Infirmary. The indications for ERCP, success rate, and complications were studied separately. Correlation analysis was conducted using Spearman's rank correlation coefficient. The binary logistic regression model was used to compute the factors associated with successful ERCP. Significance was established when the two-sided P-value < 0.05. Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) software version 25 for Windows (SPSS Inc., Chicago, IL, USA, 2017). Results A total of 281 ERCP were included in this study, with 169 and 112 performed during the first six months of 2019 and 2020, respectively. A statistically significant (0.0087) higher proportion of cases with liver dysfunction presented for ERCP before the COVID-19 outbreak (152, 89.94%). All patients before COVID-19 underwent wire control-assisted ERCP, while 82 (73.21%) received assisted ERCP during the first wave (P < 0.001). There was no statistically significant difference (P = 0.10) in the number of patients who underwent sphincterotomy before and during the first wave of COVID-19, with 97 (57.39%) and 76 (67.85%), respectively. The success rate of ERCP before COVID-19 was relatively high, accounting for 146 (86.39%) patients in contrast to 87 (77.67%) patients during the first wave (P = 0.074). Sphincterotomy (

Identifiants

pubmed: 34522563
doi: 10.7759/cureus.17861
pmc: PMC8429881
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17861

Informations de copyright

Copyright © 2021, Gadour et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Dig Dis Sci. 2021 Jun;66(6):1845-1851
pubmed: 33755824
Dig Endosc. 2020 Sep;32(6):844-850
pubmed: 32569438
Gastrointest Endosc. 2020 Oct;92(4):925-935
pubmed: 32535193
JAMA. 2018 Nov 20;320(19):2050
pubmed: 30458491
Gastroenterol Hepatol (N Y). 2013 Aug;9(8):496-504
pubmed: 24719597
Gastroenterology. 2020 Oct;159(4):1579-1581.e5
pubmed: 32534934
Gastrointest Endosc. 2020 Jul;92(1):192-197
pubmed: 32179106
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Gut. 2021 Mar;70(3):537-543
pubmed: 32690602
Gastrointest Endosc. 2010 May;71(6):934-9, 939.e1-2
pubmed: 20226455
Gut. 2020 Dec;69(12):2063-2070
pubmed: 32503846
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
World J Gastroenterol. 2021 Feb 14;27(6):449-469
pubmed: 33642821
Healthcare (Basel). 2021 Jan 19;9(1):
pubmed: 33477942
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1636-1637
pubmed: 32205220
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Arab J Gastroenterol. 2020 Sep;21(3):156-161
pubmed: 32912748
Gastrointest Endosc. 2020 Aug;92(2):440-445.e6
pubmed: 32268135
Gastrointest Endosc. 1998 Jul;48(1):1-10
pubmed: 9684657
Gastrointest Endosc. 2020 Oct;92(4):914-924
pubmed: 32534053
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Gastrointest Endosc. 1979 Aug;25(3):102-3
pubmed: 499724
Dig Dis. 2021;39(5):540-548
pubmed: 32836219
N Engl J Med. 1993 Jan 28;328(4):228-32
pubmed: 8418402
Endoscopy. 2021 Feb;53(2):166-170
pubmed: 33080630
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Apr 25;23(4):327-331
pubmed: 32306597
Gastrointest Endosc. 2020 Sep;92(3):743-747.e1
pubmed: 32437712
Therap Adv Gastroenterol. 2020 Dec 21;13:1756284820980671
pubmed: 33425011
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Gastroenterology. 2020 Aug;159(2):772-774.e13
pubmed: 32376410
Scand J Gastroenterol. 2020 Aug;55(8):976-978
pubmed: 32643467
Lancet. 2020 Mar 14;395(10227):e46
pubmed: 32113507
Gastrointest Endosc. 1992 Jul-Aug;38(4):444-9
pubmed: 1511819
Clin Med (Lond). 2020 Jul;20(4):352-358
pubmed: 32518104

Auteurs

Eyad Gadour (E)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Okwudili Agu (O)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Mutwakil Musharaf (M)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Megan Dixon (M)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Amr Askar (A)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Siddrah Hafeez (S)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Yousuf Shafiq (Y)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Abdalla Arabiyat (A)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Julia Moradi (J)

Gastroenterology and Hepatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, GBR.

Classifications MeSH